Urelumab alone or in combination with rituximab in patients with relapsed or refractory B‐cell lymphoma
Overview of attention for article published in American Journal of Hematology, February 2020
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (79th percentile)
-
Good Attention Score compared to outputs of the same age and source (78th percentile)
Readers on
- mendeley
- 83 Mendeley